STOCK TITAN

Biomerica to Participate at BTIG Biotech Conference

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Biomerica Inc. (NASDAQ: BMRA) announced participation in the 2022 BTIG Biotechnology Conference on August 8-9 in New York City. The CEO will engage in one-on-one meetings at the event. Biomerica specializes in biomedical technologies, developing diagnostic and therapeutic products for gastrointestinal and inflammatory diseases. Their offerings aim to improve health outcomes while reducing healthcare costs.

Loading...
Loading translation...
Argus Session date unavailable
+0.33% session move Open Argus
Details

News Market Reaction – BMRA

The recorded move for BMRA in the trading session of this news was +0.33%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that the Company’s CEO will participate at the 2022 BTIG Biotechnology Conference being held in person in New York City on Monday, August 8th and Tuesday August 9th, 2022. The Company’s CEO will also be available for in-person one-on-one meetings at the conference.

About Biomerica NASDAQ: BMRA)

Biomerica, Inc. (www.biomerica.com) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories, for detection and/or treatment of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.

CONTACT INFORMATION

John Nesbett / Jennifer Belodeau
IMS Investor Relations
203.972.9200
jnesbett@institutionalms.com

 


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Biomerica participate in the BTIG Biotechnology Conference?

Biomerica will participate in the BTIG Biotechnology Conference on August 8-9, 2022.

Who will represent Biomerica at the 2022 BTIG Biotechnology Conference?

The CEO of Biomerica will represent the company at the conference.

What is the focus area of Biomerica's products?

Biomerica primarily focuses on diagnostic and therapeutic products for gastrointestinal and inflammatory diseases.

What is Biomerica's stock symbol?

Biomerica's stock symbol is BMRA.

Keep reading